Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Shreemanta Parida"'
Autor:
Martin Rao, Nathalie Cadieux, Megan Fitzpatrick, Steven Reed, Sergei Arsenian, Davide Valentini, Shreemanta Parida, Ernest Dodoo, Alimuddin Zumla, Markus Maeurer
Publikováno v:
International Journal of Infectious Diseases, Vol 56, Iss C, Pp 274-282 (2017)
Objectives: Advances in tuberculosis (TB) vaccine development are urgently required to enhance global disease management. We evaluated the potential of Mycobacterium tuberculosis (M. tb)-derived protein antigens Rv0447c, Rv2957 and Rv2958c to boost B
Externí odkaz:
https://doaj.org/article/08c4c8eb84784b7f971fa5e5517756cf
Autor:
Fergal J. Duffy, January Weiner, Scott Hansen, David L. Tabb, Sara Suliman, Ethan Thompson, Jeroen Maertzdorf, Smitha Shankar, Gerard Tromp, Shreemanta Parida, Drew Dover, Michael K. Axthelm, Jayne S. Sutherland, Hazel M. Dockrell, Tom H. M. Ottenhoff, Thomas J. Scriba, Louis J. Picker, Gerhard Walzl, Stefan H. E. Kaufmann, Daniel E. Zak, The GC6-74 Consortium, S. H. E. Kaufmann, S. K. Parida, R. Golinski, J. Maertzdorf, J. Weiner, M. Jacobson, G. McEwen, G. Walzl, G. F. Black, G. van der Spuy, K. Stanley, M. Kriel, N. Du Plessis, N. Nene, A. G. Loxton, N. N. Chegou, S. Suliman, T. Scriba, M. Fisher, H. Mahomed, J. Hughes, K. Downing, A. Penn-Nicholson, H. Mulenga, B. Abel, M. Bowmaker, B. Kagina, W. Kwong, C. W. Hanekom, T. H. M. Ottenhoff, M. R. Klein, M. C. Haks, K. L. Franken, A. Geluk, K. E. van Meijgaarden, S. A. Joosten, D. van Baarle, F. Miedema, W. H. Boom, B. Thiel, J. Sadoff, D. Sizemore, S. Ramachandran, L. Barker, M. Brennan, F. Weichold, S. Muller, L. Geiter, G. Schoolnik, G. Dolganov, T. Van, H. Mayanja-Kizza, M. Joloba, S. Zalwango, M. Nsereko, B. Okwera, H. Kisingo, H. M. Dockrell, S. Smith, P. Gorak-Stolinska, Y.-G. Hur, M. Lalor, J.-S. Lee, A. C. Crampin, N. French, B. Ngwira, A. B. Smith, K. Watkins, L. Ambrose, F. Simukonda, H. Mvula, F. Chilongo, J. Saul, K. Branson, D. Kassa, A. Abebe, T. Mesele, B. Tegbaru, R. Howe, A. Mihret, A. Aseffa, Y. Bekele, R. Iwnetu, M. Tafesse, L. Yamuah, M. Ota, J. Sutherland, P. Hill, R. Adegbola, T. Corrah, M. Antonio, T. Togun, I. Adetifa, S. Donkor, P. Andersen, I. Rosenkrands, M. Doherty, K. Weldingh
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
There remains a pressing need for biomarkers that can predict who will progress to active tuberculosis (TB) after exposure to Mycobacterium tuberculosis (MTB) bacterium. By analyzing cohorts of household contacts of TB index cases (HHCs) and a string
Externí odkaz:
https://doaj.org/article/1eba36dc045c44aa95b786e37918a63e
Surgical Treatment of Complications of Pulmonary Tuberculosis, including Drug-Resistant Tuberculosis
Autor:
Rajhmun Madansein, Shreemanta Parida, Nesri Padayatchi, Nalini Singh, Iqbal Master, Kantharuben Naidu, Alimuddin Zumla, Markus Maeurer
Publikováno v:
International Journal of Infectious Diseases, Vol 32, Iss C, Pp 61-67 (2015)
Surgery for drug-resistant tuberculosis has been shown to be safe and effective, with similar level of mortalities associated with surgical intervention observed with that for lung cancer. While surgery has been an option to treat TB in the pre-antib
Externí odkaz:
https://doaj.org/article/4ebd73ed6b694d09b1285d5c16522b85
Autor:
Joel Fleury Djoba Siawaya, Teri Roberts, Chantal Babb, Gillian Black, Hawa Jande Golakai, Kim Stanley, Nchinya Bennedict Bapela, Eileen Hoal, Shreemanta Parida, Paul van Helden, Gerhard Walzl
Publikováno v:
PLoS ONE, Vol 3, Iss 7, p e2535 (2008)
The recent introduction of fluorescent bead-based technology, allowing the measurement of multiples analytes in a single 25-50 microl sample has revolutionized the study of cytokine responses. However, such multiplex approaches may compromise the abi
Externí odkaz:
https://doaj.org/article/5b4c2211b2714b369b6d09b19ec33357
Autor:
Steven G. Reed, Shreemanta Parida, Megan B. Fitzpatrick, Nathalie Cadieux, Martin Rao, Sergei Arsenian, Ernest Dodoo, Markus Maeurer, Alimuddin Zumla, Davide Valentini
Publikováno v:
International Journal of Infectious Diseases, Vol 56, Iss C, Pp 274-282 (2017)
Objectives Advances in tuberculosis (TB) vaccine development are urgently required to enhance global disease management. We evaluated the potential of Mycobacterium tuberculosis ( M. tb )-derived protein antigens Rv0447c, Rv2957 and Rv2958c to boost
Autor:
Alimuddin Zumla, Martin Rao, Markus Maeurer, Davide Valentini, Shreemanta Parida, Ernest Dodoo, Thomas Poiret, Susanna Brighenti
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
The protective role of B cells and humoral immune responses in tuberculosis infection has been regarded as inferior to cellular immunity directed to the intracellular pathogen Mycobacterium tuberculosis. However, B-cell–mediated immune responses in
Autor:
Jan Heyckendorf, Aditya Ambati, Alimuddin Zumla, Thomas Poiret, Ernest Dodoo, Davide Valentini, Shreemanta Parida, Elena Rangelova, Markus Maeurer, Giovanni Ferrara, Christoph Lange, Liu Zhenjiang, Martin Rao, Qingda Meng
Publikováno v:
Clinical Infectious Diseases. 61:S217-S224
The emergence of drug-resistant tuberculosis is challenging tuberculosis control worldwide. In the absence of an effective vaccine to prevent primary infection with Mycobacterium tuberculosis and tuberculosis disease, host-directed therapies may offe
Autor:
Nesri Padayatchi, Nalini Singh, Alimuddin Zumla, Kantharuben Naidu, Rajhmun Madansein, Markus Maeurer, Iqbal Master, Shreemanta Parida
Publikováno v:
International Journal of Infectious Diseases, Vol 32, Iss C, Pp 32-38 (2015)
SummaryCellular therapy now offer promise of potential adjunct therapeutic options for treatment of drug-resistant tuberculosis (TB). We review here the role of Mesenchymal stromal cells, (MSCs), as well as other immune effector cells in the therapy
Autor:
Abraham Aseffa, Alimuddin Zumla, Leonard Maboko, Gita Ramjee, Timothy D. McHugh, Robert S. Wallis, Marco Schito, Neil A. Martinson, Stefan H. E. Kaufmann, Niaina Rakotosamimanana, Ian Sanne, Sayoki Mfinanga, Roxana Rustomjee, Francine Ntoumi, Voahangy Rasolofo, Cristina Vilaplana, Gibson S. Kibiki, Salim Abdulla, Nathan Kapata, Klaus Reither, Jeremiah Chakaya, Vanya Gant, Sebastien Gagneux, Michael Hoelscher, Bongani M. Mayosi, Mahdad Noursadeghi, Nesri Padayatchi, Giuseppe Ippolito, Tandakha Ndiaye Dieye, Sarah Edwards, Eleni Aklillu, James B.W. Russell, Elirehema Mfinanga, Christian Wejse, Pontiano Kaleebu, Martin Rao, Modest Mulenga, Martin P. Grobusch, Peter Mwaba, Maryline Bonnet, Eskild Petersen, Eusebio Macete, Matthew Bates, Robert J. Wilkinson, Alberto L. García-Basteiro, Thomas Nyirenda, Dorothy Yeboah-Manu, Nalini Singh, Almoustapha Issiaka Maiga, Rajhmun Madansein, Paula Munderi, Clara Menendez, Pere-Joan Cardona, Gavin J. Churchyard, Tumena Corrah, Paul T. Elkington, Aziz Sheikh, Martin Antonio, Andrie Steyn, Leopold D. Tientcheu, Bassirou Diarra, Matt Oliver, Markus Maeurer, Gill Craig, Shreemanta Parida
Publikováno v:
Nature reviews. Drug discovery, 14(8), 511-512. Nature Publishing Group
Zumla, A, Chakaya, J, Hoelscher, M, Ntoumi, F, Rustomjee, R, Vilaplana, C, Yeboah-Manu, D, Rasolof, V, Munderi, P, Singh, N, Aklillu, E, Padayatchi, N, Macete, E, Kapata, N, Mulenga, M, Kibiki, G, Mfinanga, S, Nyirenda, T, Maboko, L, Garcia-Basteiro, A, Rakotosamimanana, N, Bates, M, Mwaba, P, Reither, K, Gagneux, S, Edwards, S, Mfinanga, E, Abdulla, S, Cardona, P-J, Russell, J B W, Gant, V, Noursadeghi, M, Elkington, P, Bonnet, M, Menendez, C, Dieye, T N, Diarra, B, Maiga, A, Aseffa, A, Parida, S, Wejse, C, Petersen, E, Kaleebu, P, Oliver, M, Craig, G, Corrah, T, Tientcheu, L, Antonio, M, Rao, M, McHugh, T D, Sheikh, A, Ippolito, G, Ramjee, G, Kaufmann, S H E, Churchyard, G, Steyn, A, Grobusch, M, Sanne, I, Martinson, N, Madansein, R, Wilkinson, R J, Mayosi, B, Schito, M, Wallis, R S & Maeurer, M 2015, ' Towards host-directed therapies for tuberculosis ', Nature Reviews. Drug Discovery, vol. 14, no. 8, pp. 511-2 . https://doi.org/10.1038/nrd4696
Nature reviews. Drug discovery
Zumla, A, Chakaya, J, Hoelscher, M, Ntoumi, F, Rustomjee, R, Vilaplana, C, Yeboah-Manu, D, Rasolof, V, Munderi, P, Singh, N, Aklillu, E, Padayatchi, N, Macete, E, Kapata, N, Mulenga, M, Kibiki, G, Mfinanga, S, Nyirenda, T, Maboko, L, Garcia-Basteiro, A, Rakotosamimanana, N, Bates, M, Mwaba, P, Reither, K, Gagneux, S, Edwards, S, Mfinanga, E, Abdulla, S, Cardona, P-J, Russell, J B W, Gant, V, Noursadeghi, M, Elkington, P, Bonnet, M, Menendez, C, Dieye, T N, Diarra, B, Maiga, A, Aseffa, A, Parida, S, Wejse, C, Petersen, E, Kaleebu, P, Oliver, M, Craig, G, Corrah, T, Tientcheu, L, Antonio, M, Rao, M, McHugh, T D, Sheikh, A, Ippolito, G, Ramjee, G, Kaufmann, S H E, Churchyard, G, Steyn, A, Grobusch, M, Sanne, I, Martinson, N, Madansein, R, Wilkinson, R J, Mayosi, B, Schito, M, Wallis, R S & Maeurer, M 2015, ' Towards host-directed therapies for tuberculosis ', Nature Reviews. Drug Discovery, vol. 14, no. 8, pp. 511-2 . https://doi.org/10.1038/nrd4696
Nature reviews. Drug discovery
The treatment of tuberculosis is based on combinations of drugs that directly target Mycobacterium tuberculosis. A new global initiative is now focusing on a complementary approach of developing adjunct host-directed therapies.\ud \ud Despite the ava
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b666728b4f3be31f147adf7549f0e0ac
Autor:
Nalini Singh, Jan Andersson, Alimuddin Zumla, Martin Rao, Rebecca Axelsson-Robertson, S. Keshavjee, Markus Maeurer, Iqbal Master, Shreemanta Parida, A. Lutckii
Publikováno v:
Europe PubMed Central
The first cases of totally drug-resistant (TDR) tuberculosis (TB) were reported in Italy 10 years ago; more recently, cases have also been reported in Iran, India and South Africa. Although there is no consensus on terminology, it is most commonly de